Cylert
Company: Abbott Laboratories
Approval Status: Approved October 1998
Treatment for: Neurology, Pediatrics, Psychiatry
Areas: Neurology; Pediatrics/Neonatology; Psychiatry/Psychology
General Information
Treatment for Attention Deficit Disorder
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





